| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $3.3M | +108.9% |
| SG&A Expense | $1.2M | -38.7% |
| Operating Income | -$4.5M | -27.2% |
| Interest Expense | $108K | -21.7% |
| Pre-tax Income | -$5.0M | -40.6% |
| Net Income | -$5.0M | -40.6% |
| EPS (Basic) | -$1.15 | -40.2% |
| EPS (Diluted) | -$1.15 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $2.8M | -64.3% |
| Current Assets | $4.2M | -47.7% |
| Total Assets | $4.3M | -46.2% |
| Current Liabilities | $655K | -41.5% |
| Total Liabilities | $655K | -41.5% |
| Stockholders' Equity | $3.7M | -47.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.7M | -85.8% |
| Investing Cash Flow | $4.8M | +199.0% |
| -40.2% |